Poseida Therapeutics to Present at Two Upcoming Investor Conferences
- None.
- None.
Stifel 2023 Healthcare Conference
Date: Tuesday, November 14, 2023
Time: 8:00am ET
Piper Sandler 35th Annual Healthcare Conference
Date: Thursday, November 30, 2023
Time: 11:00am ET
Webcasts will be available on the Investors & Media Section of Poseida's website, www.poseida.com. A replay of the webcast will be available for approximately 90 days following the presentation.
About Poseida Therapeutics, Inc.
Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes allogeneic CAR-T cell therapy product candidates for both solid and liquid tumors as well as in vivo gene therapy product candidates that address patient populations with high unmet medical need. The Company's approach to cell and gene therapies is based on its proprietary genetic editing platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVER™ Site-Specific Gene Editing System and nanoparticle and hybrid gene delivery technologies as well as in-house GMP cell therapy manufacturing. The Company has formed a global strategic collaboration with Roche to unlock the promise of cell therapies for patients with hematological malignancies. Learn more at www.poseida.com and connect with us on X and LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/poseida-therapeutics-to-present-at-two-upcoming-investor-conferences-301979425.html
SOURCE Poseida Therapeutics, Inc.
FAQ
What conferences will Poseida Therapeutics, Inc. be participating in November 2023?
Where can I access the webcasts of the conferences?
How long will the webcast replay be available?
